Modulating mesothelin shedding to improve therapy

Oncotarget. 2012 Feb;3(2):114-5. doi: 10.18632/oncotarget.445.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Intramural

MeSH terms

  • ADAM Proteins / genetics
  • ADAM17 Protein
  • ADP Ribose Transferases / pharmacology*
  • Antigens, Neoplasm / immunology
  • Antigens, Neoplasm / metabolism*
  • Bacterial Toxins / pharmacology*
  • Cell Line, Tumor
  • Exotoxins / pharmacology*
  • GPI-Linked Proteins / immunology
  • GPI-Linked Proteins / metabolism*
  • Humans
  • Immunotherapy / methods*
  • Mesothelin
  • Mesothelioma / drug therapy*
  • Molecular Targeted Therapy / methods
  • Pseudomonas aeruginosa Exotoxin A
  • RNA Interference
  • RNA, Small Interfering
  • Recombinant Fusion Proteins / pharmacology*
  • Virulence Factors / pharmacology*

Substances

  • Antigens, Neoplasm
  • Bacterial Toxins
  • Exotoxins
  • GPI-Linked Proteins
  • RNA, Small Interfering
  • Recombinant Fusion Proteins
  • Virulence Factors
  • ADP Ribose Transferases
  • ADAM Proteins
  • ADAM17 Protein
  • Mesothelin